Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients.

Fouque D, Peng SC, Kopple JD.

Kidney Int. 1995 Mar;47(3):869-75.

2.
3.
4.

Pharmacokinetics of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency.

Grahnén A, Kastrup K, Heinrich U, Gourmelen M, Preece MA, Vaccarello MA, Guevara-Aguirre J, Rosenfeld RG, Sietnieks A.

Acta Paediatr Suppl. 1993 Sep;82 Suppl 391:9-13; discussion 14.

PMID:
8219484
5.

Administration of human recombinant insulin-like growth factor-I to patients following major gastrointestinal surgery.

Miell JP, Taylor AM, Jones J, Buchanan CR, Rennie J, Sherwood R, Leicester R, Ross RJ.

Clin Endocrinol (Oxf). 1992 Dec;37(6):542-51.

PMID:
1283730
6.

Insulin-like growth factor-I in patients on CAPD and hemodialysis: relationship to body weight and albumin level.

Kagan A, Altman Y, Zadik Z, Bar-Khayim Y.

Adv Perit Dial. 1995;11:234-8.

PMID:
8534712
7.

Insulin-like growth factor system components in relation to erythropoietin therapy and bone metabolism in dialyzed patients and kidney transplant recipients.

Małyszko J, Wołczyński S, Zbroch E, Brzósko S, Małyszko J, Myśliwiec M.

Nephron. 2002 Mar;90(3):282-9.

PMID:
11867949
8.

Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome.

Vaccarello MA, Diamond FB Jr, Guevara-Aguirre J, Rosenbloom AL, Fielder PJ, Gargosky S, Cohen P, Wilson K, Rosenfeld RG.

J Clin Endocrinol Metab. 1993 Jul;77(1):273-80.

PMID:
7686916
9.

Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?

Lindgren BF, Odar-Cederlöf I, Ericsson F, Brismar K.

Growth Regul. 1996 Sep;6(3):137-43.

PMID:
8894646
10.

Peritoneal loss of insulin-like growth factor-I and binding proteins in end-stage renal disease.

Bereket G, Lin JJ, Bereket A, Lang CH, Kaskel FJ.

Pediatr Nephrol. 1998 Sep;12(7):581-8.

PMID:
9761360
11.
12.

Recombinant human growth hormone therapy in malnourished dialysis patients: a randomized controlled study.

Iglesias P, Díez JJ, Fernández-Reyes MJ, Aguilera A, Burgués S, Martínez-Ara J, Miguel JL, Gómez-Pan A, Selgas R.

Am J Kidney Dis. 1998 Sep;32(3):454-63.

PMID:
9740162
13.

Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.

Díez J, Iglesias P, Sastre J, Méndez J, Selgas R, Gómez-Pan A.

Nephron. 1996;74(3):548-54.

PMID:
8938679
14.

Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.

Brody SR, Humphreys MH, Gambertoglio JG, Schoenfeld P, Cundy KC, Aweeka FT.

Clin Pharmacol Ther. 1999 Jan;65(1):21-8.

PMID:
9951427
15.

Multicenter study of change in dialysis therapy-maintenance hemodialysis to continuous ambulatory peritoneal dialysis.

Singh S, Yium J, Macon E, Clark E, Schaffer D, Teschan P.

Am J Kidney Dis. 1992 Mar;19(3):246-51.

PMID:
1553969
16.

Altered physiology and action of insulin-like growth factor 1 in skeletal muscle in chronic renal failure.

Kopple JD, Ding H, Gao XL.

Am J Kidney Dis. 1995 Jul;26(1):248-55. Review.

PMID:
7611259
17.

Growth hormone responses to pituitary and hypothalamic stimuli in CAPD patients treated with recombinant human erythropoietin.

Díez JJ, Sastre J, Iglesias P, Selgas R, Romero JR, Méndez J, Gómez-Pan A.

Adv Perit Dial. 1992;8:340-5.

PMID:
1361819
18.

Effects of short-term recombinant human growth hormone therapy on plasma leptin concentrations in dialysis patients.

Iglesias P, Díez JJ, Fernández-Reyes MJ, Bajo MA, Aguilera A, Méndez J, Codoceo R, Selgas R.

Nephrol Dial Transplant. 2002 Feb;17(2):260-4.

PMID:
11812876
19.

Effects of recombinant human insulin-like growth factor-I (rhIGF-I) on total and free IGF-I concentrations, IGF-binding proteins, and glycemic response in humans.

Lieberman SA, Bukar J, Chen SA, Celniker AC, Compton PG, Cook J, Albu J, Perlman AJ, Hoffman AR.

J Clin Endocrinol Metab. 1992 Jul;75(1):30-6.

PMID:
1377706
20.

Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.

Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.

Clin Endocrinol (Oxf). 2004 Jun;60(6):741-9.

PMID:
15163339

Supplemental Content

Support Center